US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist
  • 1.320
  • -0.060-4.35%
Close Mar 28 16:00 ET
  • 1.230
  • -0.090-6.81%
Post 16:55 ET
9.06MMarket Cap0.99P/E (TTM)

PharmaCyte Biotech Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-187.91%-509.89K
46.85%-1.05M
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
Net income from continuing operations
-391.55%-3.05M
-152.67%-1.47M
835.76%23.42M
107.73%333.76K
1,165.95%1.35M
18.92%-619.54K
248.36%2.79M
-106.04%-3.18M
-1.81%-4.32M
91.12%-126.34K
Operating gains losses
-1,591.74%-3.89M
6.68%-3.09M
-1,269.21%-23.17M
---4.17M
---2.62M
---230K
---3.31M
--1.98M
----
----
Other non cash items
----
----
----
-212.05%-195K
----
----
----
40,007.11%913.64K
399.40%174.02K
91.21%5.88K
Change In working capital
211.04%422.21K
18.98%-449.33K
-80.07%125.67K
200.58%298.89K
151.90%87.15K
123.67%135.74K
-7,954.17%-554.61K
39.82%630.62K
-3,387.23%-297.17K
-175.60%-167.93K
-Change in prepaid assets
1,024.20%285.85K
-7.87%-252.99K
2.85%19.57K
-1,026.06%-152.12K
-48.23%37.96K
-66.46%25.43K
-2.57%-234.54K
-71.18%19.03K
35.80%-13.51K
-8.26%73.33K
-Change in payables and accrued expense
23.61%136.35K
38.66%-196.34K
-82.65%106.1K
259.00%451.01K
120.39%49.19K
116.99%110.31K
-244.32%-320.07K
58.86%611.59K
-1,033.17%-283.66K
-269.66%-241.25K
Cash from discontinued investing activities
Operating cash flow
-187.91%-509.89K
46.85%-1.05M
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
Investing cash flow
Cash flow from continuing investing activities
0
0
-7M
-5M
0
-5M
0
0
0
0
Net investment purchase and sale
--0
--0
---7M
---5M
--0
---5M
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
---7M
---5M
--0
---5M
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
43.95%-3.95M
-1,534.56%-10.74M
-261.99%-10.17M
21.03%-10.71M
-148.38%-10.7M
-86.31%-7.04M
122.12%748.69K
400.44%6.28M
-115.53%-13.56M
-8,376.76%-4.31M
Net common stock issuance
43.84%-225.03K
-750.87%-1.4M
97.19%-742.18K
-107.94%-28.2M
72.73%-1.17M
89.39%-400.71K
95.13%-164.95K
-1,165.39%-26.46M
-115.52%-13.56M
-113.60%-4.31M
Net preferred stock issuance
43.95%-3.72M
-591.66%-9.34M
-126.94%-9.43M
--17.49M
---9.52M
---6.64M
---1.35M
--35M
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--0
-92.05%70
--0
--0
--0
-92.05%70
--880
--0
Net other financing activities
----
----
----
----
----
----
----
---2.26M
----
----
Cash from discontinued financing activities
Financing cash flow
43.95%-3.95M
-1,534.56%-10.74M
-261.99%-10.17M
21.03%-10.71M
-148.38%-10.7M
-86.31%-7.04M
122.12%748.69K
400.44%6.28M
-115.53%-13.56M
-8,376.76%-4.31M
Net cash flow
Beginning cash position
-71.62%20.84M
-56.29%32.64M
-26.25%50.18M
-20.33%68.04M
-15.73%61.21M
-4.60%73.43M
-9.20%74.66M
-20.33%68.04M
3,778.14%85.4M
-16.16%72.64M
Current changes in cash
63.53%-4.46M
-854.55%-11.8M
-364.95%-17.55M
-2.92%-17.86M
-140.04%-11.03M
-182.79%-12.22M
76.53%-1.24M
308.61%6.62M
-120.86%-17.35M
-269.78%-4.6M
Effect of exchange rate changes
-213.93%-1.22K
103.83%61
-59.42%183
92.99%-508
91.70%-438
141.90%1.07K
-120.97%-1.59K
-65.41%451
-256.67%-7.25K
-248.87%-5.28K
End cash Position
-73.23%16.38M
-71.62%20.84M
-56.29%32.64M
-26.25%50.18M
-26.25%50.18M
-15.73%61.21M
-4.60%73.43M
-9.20%74.66M
-20.33%68.04M
-20.33%68.04M
Free cash flow
-187.91%-509.89K
46.85%-1.05M
-208.85%-373.3K
43.29%-2.15M
-15.45%-332.96K
67.31%-177.1K
-5.59%-1.98M
131.63%342.96K
7.86%-3.79M
75.80%-288.39K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -187.91%-509.89K46.85%-1.05M-208.85%-373.3K43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K
Net income from continuing operations -391.55%-3.05M-152.67%-1.47M835.76%23.42M107.73%333.76K1,165.95%1.35M18.92%-619.54K248.36%2.79M-106.04%-3.18M-1.81%-4.32M91.12%-126.34K
Operating gains losses -1,591.74%-3.89M6.68%-3.09M-1,269.21%-23.17M---4.17M---2.62M---230K---3.31M--1.98M--------
Other non cash items -------------212.05%-195K------------40,007.11%913.64K399.40%174.02K91.21%5.88K
Change In working capital 211.04%422.21K18.98%-449.33K-80.07%125.67K200.58%298.89K151.90%87.15K123.67%135.74K-7,954.17%-554.61K39.82%630.62K-3,387.23%-297.17K-175.60%-167.93K
-Change in prepaid assets 1,024.20%285.85K-7.87%-252.99K2.85%19.57K-1,026.06%-152.12K-48.23%37.96K-66.46%25.43K-2.57%-234.54K-71.18%19.03K35.80%-13.51K-8.26%73.33K
-Change in payables and accrued expense 23.61%136.35K38.66%-196.34K-82.65%106.1K259.00%451.01K120.39%49.19K116.99%110.31K-244.32%-320.07K58.86%611.59K-1,033.17%-283.66K-269.66%-241.25K
Cash from discontinued investing activities
Operating cash flow -187.91%-509.89K46.85%-1.05M-208.85%-373.3K43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K
Investing cash flow
Cash flow from continuing investing activities 00-7M-5M0-5M0000
Net investment purchase and sale --0--0---7M---5M--0---5M--0--0--0--0
Cash from discontinued investing activities
Investing cash flow --0--0---7M---5M--0---5M--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 43.95%-3.95M-1,534.56%-10.74M-261.99%-10.17M21.03%-10.71M-148.38%-10.7M-86.31%-7.04M122.12%748.69K400.44%6.28M-115.53%-13.56M-8,376.76%-4.31M
Net common stock issuance 43.84%-225.03K-750.87%-1.4M97.19%-742.18K-107.94%-28.2M72.73%-1.17M89.39%-400.71K95.13%-164.95K-1,165.39%-26.46M-115.52%-13.56M-113.60%-4.31M
Net preferred stock issuance 43.95%-3.72M-591.66%-9.34M-126.94%-9.43M--17.49M---9.52M---6.64M---1.35M--35M--0--0
Proceeds from stock option exercised by employees --0--0--0-92.05%70--0--0--0-92.05%70--880--0
Net other financing activities -------------------------------2.26M--------
Cash from discontinued financing activities
Financing cash flow 43.95%-3.95M-1,534.56%-10.74M-261.99%-10.17M21.03%-10.71M-148.38%-10.7M-86.31%-7.04M122.12%748.69K400.44%6.28M-115.53%-13.56M-8,376.76%-4.31M
Net cash flow
Beginning cash position -71.62%20.84M-56.29%32.64M-26.25%50.18M-20.33%68.04M-15.73%61.21M-4.60%73.43M-9.20%74.66M-20.33%68.04M3,778.14%85.4M-16.16%72.64M
Current changes in cash 63.53%-4.46M-854.55%-11.8M-364.95%-17.55M-2.92%-17.86M-140.04%-11.03M-182.79%-12.22M76.53%-1.24M308.61%6.62M-120.86%-17.35M-269.78%-4.6M
Effect of exchange rate changes -213.93%-1.22K103.83%61-59.42%18392.99%-50891.70%-438141.90%1.07K-120.97%-1.59K-65.41%451-256.67%-7.25K-248.87%-5.28K
End cash Position -73.23%16.38M-71.62%20.84M-56.29%32.64M-26.25%50.18M-26.25%50.18M-15.73%61.21M-4.60%73.43M-9.20%74.66M-20.33%68.04M-20.33%68.04M
Free cash flow -187.91%-509.89K46.85%-1.05M-208.85%-373.3K43.29%-2.15M-15.45%-332.96K67.31%-177.1K-5.59%-1.98M131.63%342.96K7.86%-3.79M75.80%-288.39K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More